Page last updated: 2024-08-18

pyrroles and Neoplasms, Squamous Cell

pyrroles has been researched along with Neoplasms, Squamous Cell in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aliff, T; Fleisher, M; Fury, MG; Gerald, W; Hann, L; Lis, E; Pfister, DG; Venkatraman, E; Wong, R; Zahalsky, A	1

Trials

1 trial(s) available for pyrroles and Neoplasms, Squamous Cell

Article	Year
A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers. Investigational new drugs, 2007, Volume: 25, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Blood Pressure; Female; Head and Neck Neoplasms; Heart Rate; Humans; Indoles; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Pyrroles; Regional Blood Flow; Ultrasonography; Vascular Endothelial Growth Factor A	2007

Article

Year

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers.

Investigational new drugs, 2007, Volume: 25, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Blood Pressure; Female; Head and Neck Neoplasms; Heart Rate; Humans; Indoles; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Pyrroles; Regional Blood Flow; Ultrasonography; Vascular Endothelial Growth Factor A

2007

Other Studies

1 other study(ies) available for pyrroles and Neoplasms, Squamous Cell

Article	Year
Off-label uses of sorafenib and sunitinib. Technology Evaluation Center Assessment Program. Executive summary, 2008, Volume: 22, Issue:11 Topics: Adenocarcinoma; Angiogenesis Inhibitors; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Digestive System Neoplasms; Drug Approval; Female; Gastrointestinal Stromal Tumors; Head and Neck Neoplasms; Humans; Indoles; Male; Melanoma; Neoplasms, Squamous Cell; Product Labeling; Pyridines; Pyrroles; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration	2008

Article

Year

Off-label uses of sorafenib and sunitinib.

Technology Evaluation Center Assessment Program. Executive summary, 2008, Volume: 22, Issue:11

Topics: Adenocarcinoma; Angiogenesis Inhibitors; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Digestive System Neoplasms; Drug Approval; Female; Gastrointestinal Stromal Tumors; Head and Neck Neoplasms; Humans; Indoles; Male; Melanoma; Neoplasms, Squamous Cell; Product Labeling; Pyridines; Pyrroles; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration

2008